23.15
price down icon4.10%   -0.99
after-market Handel nachbörslich: 23.15
loading

Apellis Pharmaceuticals Inc Aktie (APLS) Neueste Nachrichten

pulisher
06:02 AM

Apellis Pharmaceuticals Inc.’s volatility index tracking explained2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com

06:02 AM
pulisher
01:37 AM

Real time scanner hits for Apellis Pharmaceuticals Inc. explainedMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com

01:37 AM
pulisher
12:27 PM

Key resistance and support levels for Apellis Pharmaceuticals Inc.Earnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com

12:27 PM
pulisher
Oct 13, 2025

Can Apellis Pharmaceuticals Inc. stock surprise with earnings upsideTrade Performance Summary & Target Return Focused Stock Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How sentiment analysis helps forecast Apellis Pharmaceuticals Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to integrate Apellis Pharmaceuticals Inc. into portfolio analysis tools2025 Market Trends & Verified Trade Idea Suggestions - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Applying chart zones and confluence areas to Apellis Pharmaceuticals Inc.Earnings Overview Report & Daily Technical Stock Forecast Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What high frequency data says about Apellis Pharmaceuticals Inc.July 2025 Update & High Accuracy Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to forecast Apellis Pharmaceuticals Inc. trends using time seriesQuarterly Risk Review & Free Expert Verified Stock Movement Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Using R and stats models for Apellis Pharmaceuticals Inc. forecastingDividend Hike & Proven Capital Preservation Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Eastern Bank Cuts Position in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Oct 13, 2025
pulisher
Oct 12, 2025

What analysts say about Apellis Pharmaceuticals Inc stockVWAP Trading Strategies & Master Stock Selection - earlytimes.in

Oct 12, 2025
pulisher
Oct 10, 2025

Complement 3 Glomerulopathy Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | ChemoCentryx, Novartis, Omeros Corporation, Apellis Pharma - Barchart.com

Oct 10, 2025
pulisher
Oct 10, 2025

Price momentum metrics for Apellis Pharmaceuticals Inc. explainedQuarterly Trade Summary & Daily Technical Stock Forecast Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using Bollinger Bands to evaluate Apellis Pharmaceuticals Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Identifying reversal signals in Apellis Pharmaceuticals Inc.2025 Performance Recap & AI Driven Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Fierce Biotech Layoff Tracker 2025: Ascidian Tx trims team; Ferring plots 500 layoffs - fiercebiotech.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to monitor Apellis Pharmaceuticals Inc. with trend dashboardsJuly 2025 Retail & Reliable Price Breakout Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why retail investors pile into Apellis Pharmaceuticals Inc. stock2025 Support & Resistance & Momentum Based Trading Signals - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reiterates Sell (E+) Rating for Apellis Pharmaceuticals (NASDAQ:APLS) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Using data tools to time your Apellis Pharmaceuticals Inc. exitJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Piper Sandler Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Raises Target Price to $28 - 富途牛牛

Oct 06, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 07:38:09 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Volume spikes in Apellis Pharmaceuticals Inc. stock – what they meanJuly 2025 Drop Watch & Fast Moving Trade Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Apellis Pharmaceuticals Inc. (1JK) stock sustain institutional flows2025 Price Momentum & Smart Money Movement Tracker - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Smart tools for monitoring Apellis Pharmaceuticals Inc.’s price action2025 Market Outlook & Verified Swing Trading Watchlist - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Candlestick signals on Apellis Pharmaceuticals Inc. stock todayWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

J. Safra Sarasin Holding AG Buys 68,588 Shares of Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS) - MSN

Oct 04, 2025
pulisher
Oct 03, 2025

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Oct 03, 2025
pulisher
Oct 03, 2025

What Fibonacci levels say about Apellis Pharmaceuticals Inc. reboundTrade Signal Summary & Entry Point Strategy Guides - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What MACD and RSI say about Apellis Pharmaceuticals Inc.2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

HC Wainwright Brokers Lower Earnings Estimates for APLS - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

Apellis Pharmaceuticals: Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders - Seeking Alpha

Sep 30, 2025
pulisher
Sep 30, 2025

Apellis Pharmaceuticals CFO Timothy Sullivan sells $51,827 in stock - MSN

Sep 30, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):